Castle Biosciences, Inc. · NASDAQ:CSTL

Maetzold Derek J sold 14,518 Castle Biosciences, Inc. shares (Form 4)

Traded Sep 11, 2026 · Filed Sep 15, 2026

On Sep 11, 2026, Maetzold Derek J (Director, Pres. & Chief Exec. Officer) sold 14,518 Castle Biosciences, Inc. shares at an average US$32.02 for US$465K under a trading plan, leaving 12,268 shares. Filed Sep 15, 2026 (Form 4).

Sold
14,518 shares
Price
US$32.02 average (US$32.00 to US$32.78)
Value
US$465K
Holding after
12,268 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Pres. & Chief Exec. Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 11, 2026Common StockOption exercise8,584US$2.3930,063Direct
Sep 11, 2026Common StockSale8,361US$32.0021,702Direct
Sep 11, 2026Common StockSale3,124US$32.0014,517Indirect
Sep 11, 2026Common StockSale2,656US$32.0012,339Indirect
Sep 11, 2026Common StockSale223US$32.7821,479Direct
Sep 11, 2026Common StockSale83US$32.7814,434Indirect
Sep 11, 2026Common StockSale71US$32.7812,268Indirect

Source

View original at SEC

Related